SCHEMBL17028845

SCHEMBL17028845

CCOC(=O)N1CCN(Cc2c(Cc3c(Cl)cccc3Cl)c[nH]c(=O)c2O)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.60
TDP1 Q9NUW8 3/20 0.60
ALOX15 P16050 1/20 0.60
KDM4E B2RXH2 9/20 0.51
MAPT P10636 6/20 0.47
KMT2A Q03164 5/20 0.47
MPI P34949 2/20 0.47
HTT P42858 2/20 0.47
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
GAA P10253 2/20 0.46
POLB P06746 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.43
TSHR P16473 2/20 0.43
HSD17B10 Q99714 1/20 0.43
KCNH2 Q12809 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MCL1 Q07820 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17028842 0.92 ALDH1A1 (0.56) ALDH1A1TDP1ALOX15KDM4EMAPT
SCHEMBL17028829 0.86 ALDH1A1 (0.50) ALDH1A1TDP1ALOX15KDM4EMAPT
SCHEMBL17028823 0.86 ALDH1A1 (0.48) ALDH1A1TDP1ALOX15KDM4EMAPT
SCHEMBL17028834 0.84 ALDH1A1 (0.45) ALDH1A1TDP1ALOX15KDM4EMAPT
SCHEMBL17028828 0.83 ALDH1A1 (0.48) ALDH1A1TDP1ALOX15KDM4EMAPT
SCHEMBL17028830 0.82 ALDH1A1 (0.46) ALDH1A1TDP1ALOX15KDM4EMAPT
SCHEMBL17028844 0.79 ALDH1A1 (0.52) ALDH1A1TDP1ALOX15KDM4EMAPT
SCHEMBL17028837 0.77 ALDH1A1 (0.43) ALDH1A1KDM4EMAPTKMT2AHTT
SCHEMBL17028840 0.76 L3MBTL1 (0.40) ALDH1A1KDM4EMAPTKMT2AHTT
SCHEMBL17028815 0.75 ALDH1A1 (0.47) ALDH1A1TDP1ALOX15KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3107542-A1 PROCESS FOR PREPARING N-BENZYL-3-HYDROXY-4-SUBSTITUTED-PYRIDIN-2-(1H)-ONES Aerpio Therapeutics, Inc. (US) 2016-12-28 EP disclosed
WO-2015126860-A1 PROCESS FOR PREPARING N-BENZYL-3-HYDROXY-4-SUBSTITUTED-PYRIDIN-2-(1H)-ONES AERPIO THERAPEUTICS, INC. (US) 2015-08-27 WO disclosed